Evaluation for Potential Drug–Drug Interaction of MT921 Using In Vitro Studies and Physiologically–Based Pharmacokinetic Models

作者
Hyo‐jeong Ryu,Hyun-ki Moon,Jun‐Ho Lee,Gi‐Hyeok Yang,Sung‐yoon Yang,Hwi‐yeol Yun,Jung‐woo Chae,Won-Ho Kang
出处
期刊:Pharmaceuticals [Multidisciplinary Digital Publishing Institute]
卷期号:14 (7): 654-654 被引量:4
标识
DOI:10.3390/ph14070654
摘要

MT921 is a new injectable drug developed by Medytox Inc. to reduce submental fat. Cholic acid is the active pharmaceutical ingredient, a primary bile acid biosynthesized from cholesterol, endogenously produced by liver in humans and other mammals. Although individuals treated with MT921 could be administered with multiple medications, such as those for hypertension, diabetes, and hyperlipidemia, the pharmacokinetic drug–drug interaction (DDI) has not been investigated yet. Therefore, we studied in vitro against drug-metabolizing enzymes and transporters. Moreover, we predicted the potential DDI between MT921 and drugs for chronic diseases using physiologically-based pharmacokinetic (PBPK) modeling and simulation. The magnitude of DDI was found to be negligible in in vitro inhibition and induction of cytochrome P450s and UDP-glucuronosyltransferases. Organic anion transporting polypeptide (OATP)1B3, organic anion transporter (OAT)3, Na+-taurocholate cotransporting polypeptide (NTCP), and apical sodium-dependent bile acid transporter (ASBT) are mainly involved in MT921 transport. Based on the result of in vitro experiments, the PBPK model of MT921 was developed and evaluated by clinical data. Furthermore, the PBPK model of amlodipine was developed and evaluated. PBPK DDI simulation results indicated that the pharmacokinetics of MT921 was not affected by the perpetrator drugs. In conclusion, MT921 could be administered without a DDI risk based on in vitro study and related in silico simulation. Further clinical studies are needed to validate this finding.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
嘻嘻哈哈的应助被yuqinghui98采纳,获得10
刚刚
有梦想的人完成签到,获得积分10
刚刚
英姑的应助被轻松翰采纳,获得10
刚刚
刚刚
小宅女完成签到 ,获得积分10
刚刚
wrwywzx完成签到,获得积分10
2秒前
魔法少女完成签到,获得积分10
2秒前
wm13完成签到,获得积分10
2秒前
小柚子完成签到,获得积分10
2秒前
3秒前
3秒前
共享精神的应助被peng采纳,获得10
3秒前
adm0616完成签到,获得积分10
4秒前
汉堡包的应助被李晓彤采纳,获得10
4秒前
wolaile35完成签到,获得积分10
4秒前
4秒前
4秒前
joy完成签到 ,获得积分10
4秒前
5秒前
麻薯酸奶完成签到,获得积分10
5秒前
开心易真完成签到 ,获得积分10
5秒前
李健的小迷弟的应助被zxy采纳,获得10
5秒前
Let It Be完成签到 ,获得积分10
5秒前
6秒前
风吹麦浪的应助被wrwywzx采纳,获得10
6秒前
6秒前
兰洲完成签到,获得积分10
7秒前
ubless607的应助被xzn1123采纳,获得10
7秒前
爆米花的应助被chenchen采纳,获得10
8秒前
深情安青的应助被HHH采纳,获得10
8秒前
123嗯呐完成签到,获得积分10
8秒前
8秒前
8秒前
女巫在跳舞完成签到,获得积分10
8秒前
8秒前
9秒前
10秒前
yin发布了新的文献求助10
10秒前
英俊的铭的应助被rilin采纳,获得10
10秒前
爆米花的应助被rong采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182664
求助须知:如何正确求助?哪些是违规求助? 9572061
关于积分的说明 21822050
捐赠科研通 7779160
什么是DOI,文献DOI怎么找? 3433702
关于科研通互助平台的介绍 2557882
邀请新用户注册赠送积分活动 2479766